Inergetics Completes Phase I Development of its Therapeutic CBD Line of Products

NEWARK, N.J., July 29, 2014 /PRNewswire via COMTEX/ Inergetics, Inc. (OTCBB: NRTI), a leading developer of nutritional supplements, today announced the successful completion of its first phase towards the formulation of its proprietary line of natural cannabidiol CBD-based nutritional supplements it is developing in partnership with Terra Tech Corp (OCTBB: TRTC). Research shows that cannabinoids have medical application for a range of conditions as varied as epilepsy, glaucoma, osteoporosis, anorexia, Alzheimer s disease and pain treatment. Following the recent success of the CBD Medical Advisory Board meeting led by Inergetics Chief Science Officer, Carl Germano, RD, CNS, CDN, Inergetics has successfully procured targeted cannabinoids from industrial hemp, cannabis and other unique dietary sources. This is a critical milestone for us in our quest to enter the marketplace as the gold standard of cannabinoid supplements, says Germano. Innovation in cannabinoid extraction from food so
http://bit.ly/1qIDRq3